Select Publications

Journal articles

Villa Nova M; Lin TP; Shanehsazzadeh S; Jain K; Ng SCY; Wacker R; Chichakly K; Wacker MG, 2022, 'Nanomedicine Ex Machina: Between Model-Informed Development and Artificial Intelligence', Frontiers in Digital Health, vol. 4, pp. 799341, http://dx.doi.org/10.3389/fdgth.2022.799341

Gao GF; Ashtikar M; Kojima R; Yoshida T; Kaihara M; Tajiri T; Shanehsazzadeh S; Modh H; Wacker MG, 2021, 'Predicting drug release and degradation kinetics of long-acting microsphere formulations of tacrolimus for subcutaneous injection', Journal of Controlled Release, vol. 329, pp. 372 - 384, http://dx.doi.org/10.1016/j.jconrel.2020.11.055

Lahooti A; Shanehsazzadeh S; Laurent S, 2020, 'Preliminary studies of 68Ga-NODA-USPION-BBN as a dual-modality contrast agent for use in positron emission tomography/magnetic resonance imaging', Nanotechnology, vol. 31, http://dx.doi.org/10.1088/1361-6528/ab4446

Sakhtianchi R; Darvishi B; Mirzaie Z; Dorkoosh F; Shanehsazzadeh S; Dinarvand R, 2019, 'Pegylated magnetic mesoporous silica nanoparticles decorated with AS1411 Aptamer as a targeting delivery system for cytotoxic agents', Pharmaceutical Development and Technology, vol. 24, pp. 1063 - 1075, http://dx.doi.org/10.1080/10837450.2019.1569678

Shanehsazzadeh S; Jalilian AR; Lahooti A; Geramifar P; Beiki D; Yousefnia H; Rabiee A; Mazidi M; Mirshojaei SF; Maus S, 2017, 'Preclinical evaluation of 68Ga-MAA from commercial available 99mTc-MAA Kit', Iranian Journal of Pharmaceutical Research, vol. 16, pp. 1415 - 1423

Nikzad M; Jalilian AR; Shirvani-Arani S; Arabieh M; Shanesazzadeh S; Golchoobian H, 2017, 'Development and assessment of Sm-153-zoledronate complex as a possible bone pain palliative agent', IRANIAN JOURNAL OF NUCLEAR MEDICINE, vol. 25, pp. 81 - 91, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000405588100001&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Farzadniya A; Faeghi F; Shanehsazzadeh S, 2017, 'Quantitative Effect of Magnetic Field Strength on PEGylated Superparamagnetic Iron Oxide Nanoparticles', Applied Magnetic Resonance, vol. 48, pp. 597 - 607, http://dx.doi.org/10.1007/s00723-017-0880-2

Lahooti A; Sarkar S; Saligheh Rad H; Gholami A; Nosrati S; Muller RN; Laurent S; Grüttner C; Geramifar P; Yousefnia H; Mazidi M; Shanehsazzadeh S, 2017, 'PEGylated superparamagnetic iron oxide nanoparticles labeled with 68Ga as a PET/MRI contrast agent: a biodistribution study', Journal of Radioanalytical and Nuclear Chemistry, vol. 311, pp. 769 - 774, http://dx.doi.org/10.1007/s10967-016-5058-0

Lahooti A; Sarkar S; Laurent S; Shanehsazzadeh S, 2016, 'Dual nano-sized contrast agents in PET/MRI: a systematic review', Contrast Media and Molecular Imaging, vol. 11, pp. 428 - 447, http://dx.doi.org/10.1002/cmmi.1719

Azhdarzadeh M; Atyabi F; Saei AA; Varnamkhasti BS; Omidi Y; Fateh M; Ghavami M; Shanehsazzadeh S; Dinarvand R, 2016, 'Theranostic MUC-1 aptamer targeted gold coated superparamagnetic iron oxide nanoparticles for magnetic resonance imaging and photothermal therapy of colon cancer', Colloids and Surfaces B: Biointerfaces, vol. 143, pp. 224 - 232, http://dx.doi.org/10.1016/j.colsurfb.2016.02.058

Shanehsazzadeh S; Grüttner C; Yousefnia H; Lahooti A; Gholami A; Nosrati S; Zolghadri S; Anijdan SHM; Lotfabadi A; Varnamkhasti BS; Daha FJ; Jalilian AR, 2016, 'Development of 177Lu-DTPA-SPIO conjugates for potential use as a dual contrast SPECT/MRI imaging agent', Radiochimica Acta, vol. 104, pp. 337 - 344, http://dx.doi.org/10.1515/ract-2015-2499

Fazaeli Y; Shanehsazzadeh S; Lahooti A; Feizi S; Jalilian A, 2016, 'Preclinical dosimetric estimation of [111In] 5, 10, 15, 20-tetra phenyl porphyrin complex as a possible imaging/PDT agent', Radiochimica Acta, vol. 104, pp. 327 - 336, http://dx.doi.org/10.1515/ract-2015-2444

Nosrati S; Shanehsazzadeh S; Yousefnia H; Gholami A; Grüttner C; Jalilian AR; Hosseini RH; Lahooti A, 2016, 'Biodistribution evaluation of 166Ho–DTPA–SPION in normal rats', Journal of Radioanalytical and Nuclear Chemistry, vol. 307, pp. 1559 - 1566, http://dx.doi.org/10.1007/s10967-015-4251-x

Hajesmaeelzadeh F; Shanehsazzadeh S; Grüttner C; Daha FJ; Oghabian MA, 2016, 'Effect of coating thickness of iron oxide nanoparticles on their relaxivity in the MRI', Iranian Journal of Basic Medical Sciences, vol. 19, pp. 166 - 171

Mirsadeghi S; Shanehsazzadeh S; Atyabi F; Dinarvand R, 2016, 'Effect of PEGylated superparamagnetic iron oxide nanoparticles (SPIONs) under magnetic field on amyloid beta fibrillation process', Materials Science and Engineering C, vol. 59, pp. 390 - 397, http://dx.doi.org/10.1016/j.msec.2015.10.026

Yousefnia H; Zolghadri S; Sadeghi HR; Naderi M; Jalilian AR; Shanehsazzadeh S, 2016, 'Preparation and biological assessment of 177Lu-BPAMD as a high potential agent for bone pain palliation therapy: comparison with 177Lu-EDTMP', Journal of Radioanalytical and Nuclear Chemistry, vol. 307, pp. 1243 - 1251, http://dx.doi.org/10.1007/s10967-015-4225-z

Shanehsazzadeh S; Lahooti A; Hajipour MJ; Ghavami M; Azhdarzadeh M, 2015, 'External magnetic fields affect the biological impacts of superparamagnetic iron nanoparticles', Colloids and Surfaces B: Biointerfaces, vol. 136, pp. 1107 - 1112, http://dx.doi.org/10.1016/j.colsurfb.2015.11.028

Fakhari A; Jalilian AR; Yousefnia H; Shanehsazzadeh S; Samani AB; Daha FJ; Ardestani MS; Khalaj A, 2015, 'Preparation, Biological Evaluation and Dosimetry Studies of 175Yb-Bis-Phosphonates for Palliative Treatment of Bone Pain.', Mol Imaging Radionucl Ther, vol. 24, pp. 110 - 119, http://dx.doi.org/10.4274/mirt.36036

Shanehsazzadeh S; Lahooti A; Yousefnia H; Geramifar P; Jalilian AR, 2015, 'Comparison of estimated human dose of 68Ga-MAA with 99mTc-MAA based on rat data', Annals of Nuclear Medicine, vol. 29, pp. 745 - 753, http://dx.doi.org/10.1007/s12149-015-0997-z

Yousefnia H; Zolghadri S; Shanehsazzadeh S, 2015, 'Estimated human absorbed dose of 177Lu-BPAMD based on mice data: Comparison with 177Lu-EDTMP', Applied Radiation and Isotopes, vol. 104, pp. 128 - 135, http://dx.doi.org/10.1016/j.apradiso.2015.06.033

Shanehsazzadeh S; Lahooti A; Shirmardi SP; Erfani M, 2015, 'Comparison of estimated human effective dose of 67Ga- and 99mTc-labeled bombesin based on distribution data in mice', Journal of Radioanalytical and Nuclear Chemistry, vol. 305, pp. 513 - 520, http://dx.doi.org/10.1007/s10967-015-3995-7

Shanehsazzadeh S; Yousefnia H; Jalilian AR; Zolghadri S; Lahooti A, 2015, 'Estimated human absorbed dose for 68Ga-ECC based on mice data: comparison with 67Ga-ECC', Annals of Nuclear Medicine, vol. 29, pp. 475 - 481, http://dx.doi.org/10.1007/s12149-015-0967-5

Najafian N; Shanehsazzadeh S; Hajesmaeelzadeh F; Lahooti A; Gruettner C; Oghabian MA, 2015, 'Effect of Functional Group and Surface Charge of PEG and Dextran-Coated USPIO as a Contrast Agent in MRI on Relaxivity Constant', Applied Magnetic Resonance, vol. 46, pp. 685 - 692, http://dx.doi.org/10.1007/s00723-015-0667-2

Shanehsazzadeh S; Gruettner C; Lahooti A; Mahmoudi M; Allen BJ; Ghavami M; Daha FJ; Oghabian MA, 2015, 'Monoclonal antibody conjugated magnetic nanoparticles could target MUC-1-positive cells in vitro but not in vivo', Contrast Media and Molecular Imaging, vol. 10, pp. 225 - 236, http://dx.doi.org/10.1002/cmmi.1627

Sadeghzadeh M; Shanehsazzadeh S; Lahooti A, 2015, 'Assessment of the effective absorbed dose of 4-benzyl-1-(3-[125I]-iodobenzylsulfonyl)piperidine in humans on the basis of biodistribution data of rats', Nuclear Medicine Communications, vol. 36, pp. 90 - 94, http://dx.doi.org/10.1097/MNM.0000000000000210

Shanehsazzadeh S; Lahooti A, 2014, 'Biodistribution of 80 nm iron oxide nanoparticles labeled with Tc-99m in Balb/c mice', NUCLEAR MEDICINE AND BIOLOGY, vol. 41, pp. 625 - 625, http://dx.doi.org/10.1016/j.nucmedbio.2014.05.094

Shanehsazzadeh S; Yousefnia H; Lahooti A; Zolghadri S; Jalilian AR; Afarideh H, 2014, 'Assessment of human effective absorbed dose of 67 Ga–ECC based on biodistribution rat data', Annals of Nuclear Medicine, vol. 29, pp. 118 - 124, http://dx.doi.org/10.1007/s12149-014-0917-7

Omid H; Oghabian MA; Ahmadi R; Shahbazi N; Hosseini HRM; Shanehsazzadeh S; Zangeneh RN, 2014, 'Synthesizing and staining manganese oxide nanoparticles for cytotoxicity and cellular uptake investigation', Biochimica et Biophysica Acta - General Subjects, vol. 1840, pp. 428 - 433, http://dx.doi.org/10.1016/j.bbagen.2013.10.001

Shanehsazzadeh S; Oghabian MA; Lahooti A; Abdollahi M; Abolghasem Haeri S; Amanlou M; Daha FJ; Allen BJ, 2013, 'Estimated background doses of [67Ga]-DTPA-USPIO in normal Balb/c mice as a potential therapeutic agent for liver and spleen cancers', Nuclear Medicine Communications, vol. 34, pp. 915 - 925, http://dx.doi.org/10.1097/MNM.0b013e328362d2fb

Jahanbakhsh R; Atyabi F; Shanehsazzadeh S; Sobhani Z; Adeli M; Dinarvand R, 2013, 'Modified Gadonanotubes as a promising novel MRI contrasting agent', DARU, Journal of Pharmaceutical Sciences, vol. 21, http://dx.doi.org/10.1186/2008-2231-21-53

Lahooti A; Shanehsazzadeh S; Jalilian AR; Tavakoli MB, 2013, 'Assessment of effective absorbed dose of 111in-DTPA-buserelin in human on the basis of biodistribution rat data', Radiation Protection Dosimetry, vol. 154, pp. 1 - 8, http://dx.doi.org/10.1093/rpd/ncs137

Shanehsazzadeh S; Oghabian MA; Daha FJ; Amanlou M; Allen BJ, 2013, 'Biodistribution of ultra small superparamagnetic iron oxide nanoparticles in BALB mice', Journal of Radioanalytical and Nuclear Chemistry, vol. 295, pp. 1517 - 1523, http://dx.doi.org/10.1007/s10967-012-2173-4

Oghabian MA; Gharehaghaji N; Masoudi A; Shanehsazzadeh S; Ahmadi R; Majidi RF; Hosseini HRM, 2013, 'Effect of Coating Materials on Lymph Nodes Detection Using Magnetite Nanoparticles', Advanced Science, Engineering and Medicine, vol. 5, pp. 37 - 45, http://dx.doi.org/10.1166/asem.2013.1214

Shanehsazzadeh S; Oghabian MA; Allen BJ; Amanlou M; Masoudi A; Daha FJ, 2013, 'Evaluating the effect of ultrasmall superparamagnetic iron oxide nanoparticles for a long-term magnetic cell labeling', Journal of Medical Physics, vol. 38, pp. 34 - 40, http://dx.doi.org/10.4103/0971-6203.106603

Amanlou M; Siadat SD; Ebrahimi SES; Alavi A; Aghasadeghi MR; Ardestani MS; Shanehsaz S; Ghorbani M; Mehravi B; Shafiee Alavidjeh M; Jabbari-Arabzadeh A; Abbasi M, 2011, 'Gd(3+)-DTPA-DG: novel nanosized dual anticancer and molecular imaging agent.', International journal of nanomedicine, vol. 6, pp. 747 - 763

Shanehsazzadeh S; Lahooti A; Sadeghi HR; Jalilian AR, 2011, 'Estimation of human effective absorbed dose of 67Ga-cDTPA-gonadorelin based on biodistribution rat data', Nuclear Medicine Communications, vol. 32, pp. 37 - 43, http://dx.doi.org/10.1097/MNM.0b013e328340b916

Moghaddam AK; Jalilian AR; Hayati V; Shanehsazzadeh S, 2010, 'Determination of human absorbed dose of 201Tl(III)-DTPA-HIgG based on biodistribution data in rats', Radiation Protection Dosimetry, vol. 141, pp. 269 - 274, http://dx.doi.org/10.1093/rpd/ncq172

Jalilian AR; Shanehsazzadeh S; Akhlaghi M; Kamali-Dehghan M; Moradkhani S, 2010, 'Development of [111In]-DTPA-buserelin for GnRH receptor studies', Radiochimica Acta, vol. 98, pp. 113 - 119, http://dx.doi.org/10.1524/ract.2010.1689

Shanehsazzadeh S; Jalilian AR; Sadeghi HR; Allahverdi M, 2009, 'Determination of human absorbed dose of 67GA-DTPA-ACTH based on distribution data in rats', Radiation Protection Dosimetry, vol. 134, pp. 79 - 86, http://dx.doi.org/10.1093/rpd/ncp085

Jalilian AR; Shanehsazzadeh S; Akhlaghi M; Garousi J; Rajabifar S; Tavakoli MB, 2008, 'Preparation and biodistribution of [67Ga]-DTPA-gonadorelin in normal rats', Journal of Radioanalytical and Nuclear Chemistry, vol. 278, pp. 123 - 129, http://dx.doi.org/10.1007/s10967-007-7241-9

Jalilian AR; Shanehsazzadeh S; Akhlaghi M; Garoosi J; Rajabifar S; Tavakoli MB, 2008, 'Preparation and evaluation of [67Ga]-DTPA-β-1-24- corticotrophin in normal rats', Radiochimica Acta, vol. 96, pp. 435 - 439, http://dx.doi.org/10.1524/ract.2008.1512

Jalilian AR; Sardari D; Kia L; Rowshanfarzad P; Garousi J; Akhlaghi M; Shanehsazzadeh S; Mirzaii M, 2008, 'Preparation, quality control and biodistribution studies of two [ 111In]-rituximab immunoconjugates', Scientia Pharmaceutica, vol. 76, pp. 151 - 170, http://dx.doi.org/10.3797/scipharm.0804-07

JALILIAN AR; SHANESAZZADEH S; ROWSHANFARZAD P; BOLOURINOVIN F; MAJDABADI A, 2008, 'Biodistribution study of [61Cu]pyruvaldehyde-bis (N-4-methylthiosemicarbazone) in normal rats as a PET tracer', Nuclear Science and Techniques/Hewuli, vol. 19, pp. 159 - 164, http://dx.doi.org/10.1016/S1001-8042(08)60043-3

Salamat MR; Rostampour N; Shanehsazzadeh S; Tavakoli MB; Siavash M; Almasi T, 2008, 'Assessment of bone mineral density with dual energy X-ray absorptiometry in pre- and post-menopausal women', Iranian Journal of Radiation Research, vol. 6, pp. 107 - 111

Shanehsaz Zadeh S; Salehi A; Mehri A, 2007, 'Comparison of different invasive types of refractive errors operation', Journal of Isfahan Medical School, vol. 24


Back to profile page